课题基金 / 基金详情

Glucocorticoid induced G-CSF in lung inflammation

Glucocorticoid induced G-CSF in lung inflammation
糖皮质激素诱导 G-CSF 治疗肺部炎症
批准号:
9336499
负责人:
NICK LU
金额:
$39.13万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2017-01-31

项目摘要

项目成果

NICK LU的其他基金

相似基金

相关文献

中文摘要
翻译
项目概述:糖皮质激素在炎症治疗中不可或缺,尽管它们不是 有效治疗严重哮喘和急性呼吸窘迫综合征中的嗜酸性肺部炎症。 我们的长期目标是开发新的糖皮质激素方案,提高疗效/风险比。的目标 这项提议是为了确定消除G-CSF信号传导是否会使糖皮质激素促进 中性粒细胞凋亡和改善肺部炎症。我们最近发现糖皮质激素 显著升高G-CSF,一种中性粒细胞促进细胞因子。G-CSF近年来被认为是一种 类固醇抵抗性肺部炎症的原因。我们假设糖皮质激素保护中性粒细胞 并通过刺激G-CSF增强中性粒细胞功能。G-CSF诱导由GR启动 和NF-κ B B p50相互作用。糖皮质激素诱导肺产生G-CSF 常驻细胞维持肺部炎症。阻断G-CSF信号传导将增加糖皮质激素的疗效 来避免嗜肺菌引起的肺部炎症为了验证我们的假设,我们将检查体外系统, 和体内。目的1中的研究将检验GR和p50相互作用介导G-CSF表达的假设 在肺部的各种细胞类型中。目的2中的研究将确定糖皮质激素诱导的G-CSF在 中性粒细胞存活、功能、运输和两种鼠模型中的嗜中性粒细胞肺炎。我们将使用 阻断G-CSF诱导的三种方法:使用G-CSFR缺失小鼠,抗G-CSF中和抗体, 两种天然的NF-κ B B抑制剂,我们已经确定能够抑制G-CSF诱导:姜黄素和 单性木兰我们的初步数据表明,糖皮质激素受体(GR)和NF-κ B B都是必需的 用于G-CSF诱导,并且p50而不是p65被募集到与GR相同的G-CSF启动子区域。 多个肺驻留细胞和浸润性白细胞产生G-CSF糖皮质激素刺激后。 使用中和抗体阻断G-CSF信号传导可消除糖皮质激素和IL-1β对 中性粒细胞凋亡。姜黄素联合糖皮质激素降低肺G-CSF, LPS肺损伤模型中的中性粒细胞数量。建议的研究将增进我们对 糖皮质激素诱导的G-CSF在嗜中性粒细胞显性糖皮质激素耐药疾病中的作用抑制G- 预期CSF信号传导增加糖皮质激素抑制气道损伤的能力, 中性粒细胞的活性和改善肺部炎症。
英文摘要
Project Summary: Glucocorticoids are indispensable in the treatment of inflammation although they are not effective in treating neutrophilic lung inflammation in severe asthma and acute respiratory distress syndrome. Our long-term goal is to develop new glucocorticoid regimens with improved efficacy/risk ratios. The goal of this proposal is to determine whether eliminating G-CSF signaling will allow glucocorticoids to promote neutrophil apoptosis and ameliorate lung inflammation. We have recently discovered that glucocorticoids significantly elevate G-CSF, a neutrophil promoting cytokine. G-CSF in recent years has been recognized as a cause of steroid-resistant lung inflammatory disorders. We hypothesize that glucocorticoids protect neutrophil from apoptosis and enhance neutrophil function via stimulation of G-CSF. G-CSF induction is initiated by GR and NF-B p50 interaction on the G-CSF promoter. Glucocorticoid-induction of G-CSF production in lung resident cells sustains lung inflammation. Blocking G-CSF signaling will increase the efficacy of glucocorticoids in circumventing neutrophil-driven lung inflammation. To test our hypotheses, we will examine systems in vitro and in vivo. Studies in Aim 1 will test the hypothesis that GR and p50 interactions mediate G-CSF expression in various cell types in lungs. Studies in Aim 2 will determine the role of glucocorticoid-induced G-CSF in neutrophil survival, functions, trafficking, and neutrophilic lung inflammation in two murine models. We will use three approaches to block G-CSF induction: using G-CSFR null mice, anti-G-CSF neutralizing antibodies, and two natural NF-B inhibitors that we have identified to be able to inhibit G-CSF-induction: curcumin and parthenolide. Our preliminary data indicate that both the glucocorticoid receptor (GR) and NF-B were required for G-CSF induction and p50, but not p65, was recruited to the same region of G-CSF promoter as GR. Multiple lung resident cells and infiltrating leukocytes produced G-CSF upon glucocorticoid stimulation. Blocking G-CSF signaling using neutralizing antibodies abolished glucocorticoid and IL-1β protection of neutrophils from undergoing apoptosis. Curcumin in combination with glucocorticoids reduced lung G-CSF and neutrophil numbers in an LPS lung injury model. The proposed studies will improve our understanding of the role of glucocorticoid-induced G-CSF in neutrophil-dominant glucocorticoid-resistant diseases. Inhibiting G- CSF signaling is anticipated to increase the ability of glucocorticoids to suppress the airway-damaging activities of neutrophils and ameliorate lung inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glucocorticoids and glucocorticoid receptor translational isoforms
Glucocorticoids and glucocorticoid receptor translational isoforms
Glucocorticoid receptor translational isoforms in asthma
Glucocorticoid receptor translational isoforms in asthma
海外基金